This educational activity is based on the proceedings of a symposium held in conjunction with the 2021 Annual Meeting of the American Urological Association on OAB that reviewed updates in the treatment of OAB, including clinical data on new and emerging treatments, and which highlighted some of the evidence on the increased risk of dementia associated with antimuscarinic use.

In this interprofessional webcast, experts in optometric and neurologic assessment and treatment of neuromyelitis spectrum disorder (NMOSD) discuss best practices in diagnosis and referral of patients with possible NMOSD as well as clinical data supporting 3 newly approved long-term suppressive treatments specifically targeting immunologic pathways altered by NMOSD autoantibodies.

In this educational activity, experts will use cases and a debate-style format to explore different treatment options for a variety of patient scenarios.

In this educational activity, new and emerging, evidence-based strategies for evaluation, diagnosis, and treatment of dementia-related psychosis are presented, and educational tools clinicians can use in their facilities are provided.